CLIA Waived Tests Update

New Clinical Laboratory Improvement Amendments of 1988 (CLIA) waived tests approved by the Food and Drug Administration (FDA) were released Aug 27.

The CPT® codes for the following new tests must have the modifier QW CLIA waived test to be recognized as such (with the exception of code 82962).

CPT® Code Effective Date Description
G0430QW Jan. 1 Noble medical Inc. Split-Specimen Cup
82274QW, G0328QW March 1 Inverness Medical Clearview iFOBT Complete Fecal Occult Blood Test
82010QW,
82962 (no QW modifier needed)
March 2 Nova Biomedical Nova Max Plus Glucose and B-Ketone Monitoring System
83986QW April 15 Common Sense Ltd. VS-Sense Test{qualitative}
85610QW April 15 CoaguSense Self-Test Prothrombin Time/INR Monitoring System (Prescription Home Use)
G0430QW April 21 Redwood Toxicology Laboratory, Inc Reditest Freedom Cup
G0430QW April 21 Noble Medical Inc. NOBLE 1 Step Cup {OTC}
G0430QW April 30 Express Diagnostics, DrugCheck Waive Cup
G0430QW April 30 Express Diagnostics International Inc. DrugCheck Waive Multiple Drug Screen Cups
81003QW June 3 Cole-Talyor Marketing Inc. CTI-120 Urine Strip Analyzer

Note that Medicare contractors will not search their files to either retract payment for claims already paid or to retroactively pay claims processed prior to implementation of these changes. They will, however, adjust such claims you bring to their attention.

Source: MLN Matters article MM7084

dec-clearance-sale

Latest posts by admin aapc (see all)

2 Responses to “CLIA Waived Tests Update”

  1. marcia butler says:

    In your Sept. issue on the testing page, question #11 asks for the correct code for transfusions. Are these codes correct? Please check. Thank you.

  2. Lyzbeth says:

    That’s way more clever than I was exeptncig. Thanks!

Leave a Reply

Your email address will not be published. Required fields are marked *